Search for: "AstraZeneca Inc." Results 121 - 140 of 340
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jun 2011, 2:33 am by sally
& Ors, Re [2011] EWHC 1565 (Ch) (02 June 2011) Sunwing Vacation Inc & Ors v E-Clear (UK) Plc & Ors [2011] EWHC 1544 (Ch) (03 June 2011) High Court (Queen’s Bench Division) Caplin v Associated Newspapers Ltd [2011] EWHC 1567 (QB) (20 June 2011) BB & Ors v The Home Office [2011] EWHC 1446 (QB) (08 June 2011) High Court (Commercial Court) Yukos Capital SARL v OJSC Rosneft Oil Company [2011] EWHC 1461 (Comm) (14 June 2011) Astrazeneca UK Ltd v Albemarle… [read post]
10 Feb 2012, 7:32 am by Mark Zamora
 Clostridium difficile is a bacterium that can cause colitis and other intestinal conditions.The FDA said patients who develop diarrhea after taking these drugs should be checked for CDAD.The drugs called proton pump inhibitors (PPIs) are widely used for treating ulcers, acid reflux and other conditions.Other PPIs sold by prescription include Takeda Pharmaceutical Co Ltd's Dexilant and Prevacid, AstraZeneca's Prilosec and Vimovo, Santarus Inc's Zegerid, and… [read post]
1 Jun 2011, 6:08 am by Ashby Jones
A spokesman for AstraZeneca, which owns MedImmune, declined to comment. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
3 Nov 2010, 1:21 am by Kelly
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
8 Mar 2012, 3:34 am by Dan Hargrove
In April 2011, Johnson & Johnson agreed to pay $70 million to resolve violations, and The Wall Street Journal reported in November 2011 that Pfizer Inc. will pay more than $60 million when its settlement gets finalized. [read post]
23 Nov 2010, 2:00 pm by admin
The largest fiscal year 2010 False Claims Act recoveries came from the pharmaceutical and medical device industries, which accounted for $1.6 billion in settlements, including the $669 million from Pfizer Inc., $302 million from AstraZeneca, and $192.7 from Novartis Pharmaceutical Corporation. [read post]
6 Mar 2017, 10:01 am by David Jensen
“Our chief scientific officer is a former MedImmune/AstraZeneca plc (ADR) (NYSE: AZN) director. [read post]
11 Apr 2019, 10:59 am by Camilla Hrdy
He discussed it further on several posts on Sufficient Description, leading up to the Supreme Court of Canada's decision to abolish the doctrine in AstraZeneca Canada Inc. v. [read post]
1 Jun 2011, 11:22 am
" AstraZeneca, 633 F.3d at 1050. [read post]
9 Jul 2017, 3:15 am by Barry Sookman
https://t.co/tXTvWuHCR3 -> Link to new copyright parody case, United Airlines, Inc. v. [read post]
10 Jan 2018, 6:36 pm by Lawrence B. Ebert
AstraZeneca AB v.Apotex Corp., 782 F.3d 1324, 1334 (Fed. [read post]